Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Omalizumab For The Treatment of Persistent Drug Induced Urticaria Elicited By Thienopyridines: A Case Report.

Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG.

Antiinflamm Antiallergy Agents Med Chem. 2019 May 21. doi: 10.2174/1871523018666190522105055. [Epub ahead of print]

PMID:
31113348
2.

Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects.

Chaoul N, Albanesi M, Giliberti L, Rossi MP, Nettis E, Di Bona D, Caiaffa MF, Macchia L.

Int Arch Allergy Immunol. 2019;179(1):37-42. doi: 10.1159/000496436. Epub 2019 Mar 28.

PMID:
30921804
3.

Immunological characterization of onion (Allium cepa) allergy.

Albanesi M, Pasculli C, Giliberti L, Rossi MP, Di Bona D, Caiaffa MF, Macchia L.

Postepy Dermatol Alergol. 2019 Feb;36(1):98-103. doi: 10.5114/ada.2019.82829. Epub 2019 Feb 22.

4.

Idiopathic nonhistaminergic angioedema: A single-center real-life experience from Italy.

Nettis E, Di Leo E, Racanelli V, Macchia L, Vacca A.

Allergy. 2019 Feb 11. doi: 10.1111/all.13737. [Epub ahead of print] No abstract available.

PMID:
30740715
5.

Should succinate esters be considered excipients in systemic corticosteroid allergy?

Calogiuri G, Foti C, Nettis E, Di Leo E, Macchia L, Vacca A.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):342-343. doi: 10.1016/j.jaip.2018.10.047. No abstract available.

PMID:
30598184
6.

Successful treatment of four types of chronic urticaria with anti-IgE omalizumab in the same patient.

Nettis E, Di Leo E, Calogiuri G, Foti C, Macchia L.

Ann Allergy Asthma Immunol. 2019 Mar;122(3):336-337. doi: 10.1016/j.anai.2018.12.002. Epub 2018 Dec 7. No abstract available.

PMID:
30529714
7.

Delayed allergy to acyclovir revealed by lymphocyte proliferation test.

Albanesi M, Di Girolamo A, Aresta V, Rossi MP, Giliberti L, Perrone T, Di Bona D, Caiaffa MF, Specchia G, Macchia L.

Postepy Dermatol Alergol. 2018 Oct;35(5):527-529. doi: 10.5114/ada.2018.77244. Epub 2018 Jul 19. No abstract available.

8.

Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: a case report.

Di Girolamo A, Albanesi M, Sinisi A, Nettis E, Di Bona D, Caiaffa MF, Macchia L.

Clin Mol Allergy. 2018 Oct 29;16:22. doi: 10.1186/s12948-018-0100-0. eCollection 2018.

9.

Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity.

Calogiuri G, Mandurino-Mirizzi A, Parlangeli C, Macchia L, Foti C, Savage MP.

Endocr Metab Immune Disord Drug Targets. 2019;19(1):2-12. doi: 10.2174/1871530318666180914121758. Review.

PMID:
30215337
10.

Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice.

Bilò MB, Pravettoni V, Bignardi D, Bonadonna P, Mauro M, Novembre E, Quercia O, Cilia M, Cortellini G, Costantino MT, Cremonte L, Lodi Rizzini F, Macchia L, Marengo F, Murzilli F, Patella V, Reccardini F, Ricciardi L, Ridolo E, Romano A, Savi E, Schiavino D, Severino M, Pastorello EA.

J Investig Allergol Clin Immunol. 2019;29(3):180-205. doi: 10.18176/jiaci.0310. Epub 2018 Sep 5.

11.

Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review.

Di Bona D, Frisenda F, Albanesi M, Di Lorenzo G, Caiaffa MF, Macchia L.

Clin Exp Allergy. 2018 Nov;48(11):1391-1401. doi: 10.1111/cea.13242. Epub 2018 Sep 4. Review.

PMID:
30079619
12.

Focus on the agents most frequently responsible for perioperative anaphylaxis.

Di Leo E, Delle Donne P, Calogiuri GF, Macchia L, Nettis E.

Clin Mol Allergy. 2018 Jul 9;16:16. doi: 10.1186/s12948-018-0094-7. eCollection 2018. Review.

13.

Importance of Specific IgE/Total IgE Ratio in Disambiguating Amoxicillin Allergy Diagnosis in a Real-Life Setting.

Albanesi M, Sinisi A, Frisenda F, Di Bona D, Caiaffa MF, Macchia L.

Int Arch Allergy Immunol. 2018;177(2):167-169. doi: 10.1159/000489705. Epub 2018 Jun 19. No abstract available.

PMID:
29920499
14.

Use of omalizumab in uncontrolled chronic spontaneous urticaria also improved latex-induced contact urticaria.

Di Leo E, Calogiuri G, Macchia L, Nettis E.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):300-302. doi: 10.1016/j.jaip.2018.05.005. Epub 2018 May 23. No abstract available.

PMID:
29802908
15.

A desensitization protocol for delayed allergy to cytarabine: analysis of two cases.

Albanesi M, Carluccio P, Nico A, Giliberti L, Di Bona D, Caiaffa MF, Specchia G, Macchia L.

Postepy Dermatol Alergol. 2018 Apr;35(2):222-224. doi: 10.5114/ada.2018.75249. Epub 2018 Apr 24. No abstract available.

16.

A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy.

Albanesi M, Nico A, Sinisi A, Giliberti L, Rossi MP, Rossini M, Kourtis G, Rucco AS, Loconte F, Muolo L, Zurlo M, Di Bona D, Caiaffa MF, Macchia L.

Clin Mol Allergy. 2018 Jan 18;16:2. doi: 10.1186/s12948-017-0079-y. eCollection 2018.

17.

Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria.

Nettis E, Cegolon L, Macchia L, Zaza I, Calogiuri G, Di Leo E.

Acta Derm Venereol. 2018 Apr 16;98(4):446-448. doi: 10.2340/00015555-2886. No abstract available.

18.

Immunological and non-immunological mechanisms of allergic diseases in the elderly: biological and clinical characteristics.

Di Lorenzo G, Di Bona D, Belluzzo F, Macchia L.

Immun Ageing. 2017 Dec 20;14:23. doi: 10.1186/s12979-017-0105-4. eCollection 2017. Review.

19.

Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.

Di Bona D, Fiorino I, Taurino M, Frisenda F, Minenna E, Pasculli C, Kourtis G, Rucco AS, Nico A, Albanesi M, Giliberti L, D'Elia L, Caiaffa MF, Macchia L.

Respir Med. 2017 Sep;130:55-60. doi: 10.1016/j.rmed.2017.07.013. Epub 2017 Jul 19.

PMID:
29206634
20.

Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population.

Di Bona D, Accardi G, Aiello A, Bilancia M, Candore G, Colomba C, Caruso C, Duro G, Gambino CM, Macchia L, Pandey JP.

Immunology. 2018 Apr;153(4):523-531. doi: 10.1111/imm.12855. Epub 2017 Dec 11.

21.

A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis.

Giannini M, Macchia L, Amati A, Lia A, Girolamo F, D'Abbicco D, Trojano M, Iannone F.

Scand J Rheumatol. 2018 Jul;47(4):336-337. doi: 10.1080/03009742.2017.1350747. Epub 2017 Aug 5. No abstract available.

PMID:
28780890
22.

The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study.

Galimberti S, Ciabatti E, Ercolano G, Grassi S, Guerrini F, Cecconi N, Rousseau M, Cervetti G, Mazziotta F, Iovino L, Falzetti F, Falcinelli F, Bosi A, Rigacci L, Kovalchuk S, Vallisa D, Macchia L, Ciancia E, Petrini M.

Front Pharmacol. 2017 Jun 29;8:413. doi: 10.3389/fphar.2017.00413. eCollection 2017.

23.

Hypersensitivity reactions due to black henna tattoos and their components: are the clinical pictures related to the immune pathomechanism?

Calogiuri G, Di Leo E, Butani L, Pizzimenti S, Incorvaia C, Macchia L, Nettis E.

Clin Mol Allergy. 2017 Apr 10;15:8. doi: 10.1186/s12948-017-0063-6. eCollection 2017. Review.

24.

KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.

Di Bona D, Aiello A, Colomba C, Bilancia M, Accardi G, Rubino R, Giannitrapani L, Tuttolomondo A, Cascio A, Caiaffa MF, Rizzo S, Di Lorenzo G, Candore G, Duro G, Macchia L, Montalto G, Caruso C; KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group.

J Viral Hepat. 2017 Sep;24(9):768-775. doi: 10.1111/jvh.12698. Epub 2017 May 5.

PMID:
28211154
25.

Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.

Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Macchia L, Di Lorenzo G.

Allergy. 2017 May;72(5):691-704. doi: 10.1111/all.13104. Epub 2017 Jan 23. Review.

PMID:
27926981
26.

Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera).

Di Bona D, Albanesi M, Giliberti LA, Nico A, Rossi MP, Caiaffa MF, Macchia L.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):821-822. doi: 10.1016/j.jaip.2016.09.044. Epub 2016 Nov 23. No abstract available.

PMID:
27888036
27.

Hypersensitivity Reactions from Excipients in Systemic Glucocorticoid Formulations.

Calogiuri G, Garvey LH, Romita P, Macchia L, Foti C.

Antiinflamm Antiallergy Agents Med Chem. 2016;15(2):91-100. doi: 10.2174/1871523016666161109144021. Review.

PMID:
27834127
28.

Probiotics and refractory chronic spontaneous urticaria.

Nettis E, Di Leo E, Pastore A, Distaso M, Zaza I, Vacca M, Macchia L, Vacca A.

Eur Ann Allergy Clin Immunol. 2016 Sep;48(5):182-7.

29.

A joint allergist/cardiologist classification for thienopyridines hypersensitivity reactions based on their symptomatic patterns and its impact on the management strategies.

Calogiuri GF, Al-Sowaidi S, Nettis E, Cortellini G, Macchia L, Vacca A, Kounis NG.

Int J Cardiol. 2016 Nov 1;222:509-514. doi: 10.1016/j.ijcard.2016.07.115. Epub 2016 Jul 16. Review.

PMID:
27505343
30.

Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD.

Martinucci I, Savarino EV, Pandolfino JE, Russo S, Bellini M, Tolone S, Tutuian R, Roman S, Furnari M, Frazzoni M, Macchia L, Savarino V, Marchi S, de Bortoli N.

Neurogastroenterol Motil. 2016 Feb;28(2):243-50. doi: 10.1111/nmo.12719. Epub 2015 Dec 11.

PMID:
26661383
31.

Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring.

de Bortoli N, Martinucci I, Savarino EV, Frazzoni M, Tutuian R, Tolone S, Piaggi P, Furnari M, Russo S, Bertani L, Macchia L, Savarino V, Marchi S.

Dig Liver Dis. 2015 Dec;47(12):1027-32. doi: 10.1016/j.dld.2015.08.010. Epub 2015 Aug 22.

PMID:
26362613
32.

Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study.

de Bortoli N, Guidi G, Martinucci I, Savarino E, Imam H, Bertani L, Russo S, Franchi R, Macchia L, Furnari M, Ceccarelli L, Savarino V, Marchi S.

Dis Esophagus. 2016 Feb-Mar;29(2):197-204. doi: 10.1111/dote.12319. Epub 2014 Dec 17.

PMID:
25516110
33.

Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases.

Fiorino I, Loconte F, Rucco AS, Nico A, Vacca M, Damiani E, Nettis E, Caiaffa MF, Macchia L.

Postepy Dermatol Alergol. 2014 Oct;31(5):332-4. doi: 10.5114/pdia.2014.44023. Epub 2014 Oct 22. No abstract available.

34.

Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.

Novelli F, Latorre M, Vergura L, Caiaffa MF, Camiciottoli G, Guarnieri G, Matucci A, Macchia L, Vianello A, Vultaggio A, Celi A, Cazzola M, Paggiaro P; Xolair Italian Study Group.

Pulm Pharmacol Ther. 2015 Apr;31:123-9. doi: 10.1016/j.pupt.2014.09.007. Epub 2014 Sep 30.

PMID:
25281265
35.

Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β.

Macchia E, Lombardi M, Raffaelli V, Piaggi P, Macchia L, Scattina I, Martino E.

Clin Endocrinol (Oxf). 2014 Dec;81(6):921-8. doi: 10.1111/cen.12556. Epub 2014 Aug 14.

PMID:
25040256
36.

IgE-mediated reaction induced by arugula (Eruca sativa) ingestion compared with a spectrum of Brassicaceae proteins.

Damiani E, Aloia AM, Priore MG, Pastore A, Lovecchio A, Errico M, Ferrannini A, Macchia L.

Allergol Immunopathol (Madr). 2014 Sep-Oct;42(5):501-3. doi: 10.1016/j.aller.2013.05.003. Epub 2013 Jul 4. No abstract available.

PMID:
23830923
37.

Allergy to mint (Mentha spicata).

Damiani E, Aloia AM, Priore MG, Pastore A, Lippolis C, Lovecchio A, Rossi MP, Macchia L, Ferrannini A.

J Investig Allergol Clin Immunol. 2012;22(4):309-10. No abstract available.

38.

Vicia faba Hypersensitivity and ASA Intolerance in a Farmer: A Case Report.

Damiani E, Aloia AM, Priore MG, Pastore A, Nardulli S, Lippolis C, Macchia L, Ferrannini A.

J Allergy (Cairo). 2011;2011:191787. doi: 10.1155/2011/191787. Epub 2011 Jun 8.

39.

Retrospective monitoring in the management of persistent asthma.

Kourtis G, Caiaffa MF, Forte C, Scarlato MI, Macchia L.

Respir Care. 2011 May;56(5):633-43. doi: 10.4187/respcare.00796. Epub 2011 Jan 27.

40.

Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy.

Kourtis G, Rucco AS, Loconte F, Caiaffa MF, Macchia L.

J Investig Allergol Clin Immunol. 2010;20(5):451-2. No abstract available.

41.

Italian real-life experience of omalizumab.

Cazzola M, Camiciottoli G, Bonavia M, Gulotta C, Ravazzi A, Alessandrini A, Caiaffa MF, Berra A, Schino P, Di Napoli PL, Maselli R, Pelaia G, Bucchioni E, Paggiaro PL, Macchia L.

Respir Med. 2010 Oct;104(10):1410-6. doi: 10.1016/j.rmed.2010.04.013. Epub 2010 May 18.

42.

Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria.

Nettis E, Calogiuri GF, Di Leo E, Cardinale F, Macchia L, Ferrannini A, Vacca A.

J Asthma Allergy. 2008 Dec 16;2:17-23.

43.

Cyclooxygenase isozymes in oral squamous cell carcinoma:a real-time RT-PCR study with clinic pathological correlations.

Pannone G, Sanguedolce F, De Maria S, Farina E, Lo Muzio L, Serpico R, Emanuelli M, Rubini C, De Rosa G, Staibano S, Macchia L, Bufo P.

Int J Immunopathol Pharmacol. 2007 Apr-Jun;20(2):317-24.

PMID:
17624243
44.

Skin testing technique and precision in stinging insect allergy.

Corallino M, Nico A, Kourtis G, Caiaffa MF, Macchia L.

J Clin Nurs. 2007 Jul;16(7):1256-64.

PMID:
17584343
45.

Toxicity assessment of metabolites of fungal biocontrol agents using two different (Artemia salina and Daphnia magna) invertebrate bioassays.

Favilla M, Macchia L, Gallo A, Altomare C.

Food Chem Toxicol. 2006 Nov;44(11):1922-31. Epub 2006 Jul 13.

PMID:
16935403
46.

Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast.

Ramires R, Caiaffa MF, Tursi A, Haeggström JZ, Macchia L.

Biochem Biophys Res Commun. 2004 Nov 12;324(2):815-21.

PMID:
15474500
47.

Cyclooxygenase-2 expression in oral squamous cell carcinoma.

Pannone G, Bufo P, Caiaffa MF, Serpico R, Lanza A, Lo Muzio L, Rubini C, Staibano S, Petruzzi M, De Benedictis M, Tursi A, De Rosa G, Macchia L.

Int J Immunopathol Pharmacol. 2004 Sep-Dec;17(3):273-82.

PMID:
15461861
48.

Systemic adverse reaction to diclofenac administered by transdermal iontophoresis.

Macchia L, Caiaffa MF, di Gioia R, Tursi A.

Allergy. 2004 Mar;59(3):367-8. No abstract available.

PMID:
14982530
49.

Fig and mulberry cross-allergy.

Caiaffa MF, Cataldo VM, Tursi A, Macchia L.

Ann Allergy Asthma Immunol. 2003 Nov;91(5):493-5.

PMID:
14692435
50.

Grape anaphylaxis.

Caiaffa MF, Tursi A, Macchia L.

J Investig Allergol Clin Immunol. 2003;13(3):211-2.

PMID:
14635473

Supplemental Content

Loading ...
Support Center